Literature DB >> 11181803

Trends of analgesic nephropathy in two high-endemic regions with different legislation.

Paul Michielsen1, Paul DE Schepper2.   

Abstract

Analgesic abuse is related to a specific form of interstitial nephritis, but the exact nature of the causal agent remains controversial and this has resulted in differences in regulation. In Flanders, the free sale of phenacetin was banned, but the consumption of other combined analgesics remained free. In New South Wales, phenacetin was also banned, but 2 yr later the sales of all combined analgesics were also prohibited. This study compared the evolution of end-stage renal disease as a result of analgesic nephropathy (AN) in these two high-endemic regions with different legislation. In both regions, the time trend of the age-specific incidence of end-stage renal disease as a result of AN is similar in the age group 45 to 54 yr. In all age groups combined, the time trend of the percentage of AN among the patients admitted for renal replacement therapy is also similar. This finding does not support the hypothesis that non-phenacetin mixed analgesics play a significant role in the occurrence of AN.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181803     DOI: 10.1681/ASN.V123550

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  4 in total

1.  Analgesic nephropathy and renal replacement therapy in Australia: trends, comorbidities and outcomes.

Authors:  Sean Haw Chang; Timothy Hamish Mathew; Stephen Peter McDonald
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 8.237

2.  Paracetamol and analgesic nephropathy: Are you kidneying me?

Authors:  Freya Waddington; Mark Naunton; Jackson Thomas
Journal:  Int Med Case Rep J       Date:  2014-12-15

Review 3.  Common Analgesic Agents and Their Roles in Analgesic Nephropathy: A Commentary on the Evidence.

Authors:  Julian Yaxley
Journal:  Korean J Fam Med       Date:  2016-11-18

4.  Analgesics use and ESRD in younger age: a case-control study.

Authors:  Fokke J van der Woude; Lothar A J Heinemann; Helmut Graf; Michael Lewis; Sabine Moehner; Anita Assmann; Doerthe Kühl-Habich
Journal:  BMC Nephrol       Date:  2007-12-05       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.